Made available in DSpace on 2020-12-10T22:01:17Z (GMT). No. of bitstreams: 0 Previous issue date: 2011-04-15; State Univ Sao Paulo, Sao Jose Do Rio Preto, Brazil; Coll Med Sao Jose do Rio Preto, Sao Jose Do Rio Preto, Brazil; Univ Estadual Campinas, Campinas, SP, Brazil; State Univ Sao Paulo, Sao Jose Do Rio Preto, Brazil
OBJECTIVES: To evaluate whether risk scores used to classify patients with primary myelofibrosis and JAK-2 V617F mutation status can predict clinical outcome. METHODS: A review of clinical and laboratory data from 74 patients with primary myelofibrosis diagnosed between 1992 and 2011. The IPSS and Lille scores were calculated for risk stratification and correlated with overall survival. RESULTS: A V617F JAK2 mu...